Moore C

No ORCID on file · 11 papers in corpus · active 2001-2026

Study types

  • article 3
  • other 2
  • preprint 1

Condition tags

  • endometriosis 6
  • dyspareunia 1
other 2026
A mixed-methods investigation of coping, adaptation and health-related quality of life in individuals experiencing endometriosis
Psychology & health ·doi:10.1080/08870446.2026.2650778

OBJECTIVE: The current mixed-methods study aimed to investigate how individuals experiencing endometriosis coped and adapted to their condition, and the extent to which coping predicted health-related quality of life (HRQoL) over time. MET…

preprint 2024
A Mixed-Methods Investigation of Coping, Adaptation and Health-Related Quality of Life in Individuals Experiencing Endometriosis
·doi:10.1101/2024.02.19.24303022

Abstract Objectives Endometriosis is associated with reduced health-related quality of life (HRQoL). Coping has been linked to HRQoL in this population but longitudinal research to establish the impact of coping on HRQoL over time is lackin…

2022
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Vaccine ·doi:10.1016/j.vaccine.2022.04.031

BackgroundPregnant persons are at increased risk of severe illness from COVID-19 infection, including intensive care unit admission, mechanical ventilation, and death compared with non-pregnant persons of reproductive age. Limited data are …

2019
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature genetics ·doi:10.1038/s41588-019-0447-2

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

2018
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature genetics ·doi:10.1038/s41588-017-0011-x

Genome-wide association studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to neuronal biology. Most GWAS loci represent clusters of common, noncoding variants from which pinpointing causal gene…

2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature genetics ·doi:10.1038/s41588-018-0050-y

In the published version of this paper, the name of author Emanuele Di Angelantonio was misspelled. This error has now been corrected in the HTML and PDF versions of the article.

2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Nature genetics ·doi:10.1038/s41588-018-0082-3

In the version of this article originally published, one of the two authors with the name Wei Zhao was omitted from the author list and the affiliations for both authors were assigned to the single Wei Zhao in the author list. In addition, …

other 2010
Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis
Archives of gynecology and obstetrics ·doi:10.1007/s00404-009-1301-z

PURPOSE: Hormonal treatment of endometriosis is often continued for long periods and has the potential to affect many essential metabolic processes. The current study aimed to determine the effects and safety of high-dose dienogest as a med…

article 2009
Dienogest and the breast
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590902836536

In a clinical pilot study, 21 women with endometriosis have been primarely treated with dienogest 2 x 10 mg daily p.o. for 24 weeks. Besides the effect on endometriosis the action of such high-dose progestogen treatment on the breast was ev…

article 2006
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590500431482

High-dose dienogest (20 mg/day) was used for the treatment of endometriosis in women aged 18-52 years after laparoscopic and histological diagnosis of endometriosis and staging according to the revised American Fertility Society criteria. T…

article 2001
[Treatment of endometriosis with dienogest: preliminary report].
Ginekologia polska

AIM OF THE STUDY: Influence of two hormonal therapies (GnRH agonist--leuprolein acetate and a new progestin--dienogest) on symptoms of endometriosis in patients with different clinical grade of disease. MATERIAL AND METHODS: 34 women with e…